Evidence Brief: Proton Beam Therapy for Treatment of Localized Prostate Cancer

David H. Hickam; Johanna K. Anderson; Basmah Rahman; Rachel M. Ward; Nicholas J. Parr

Evidence Brief: Proton Beam Therapy for Treatment of Localized Prostate Cancer

Review

Washington (DC): Department of Veterans Affairs (US); 2022 Aug.

VA Evidence-based Synthesis Program Reports.

Authors

David H. Hickam¹, Johanna K. Anderson², Basmah Rahman³, Rachel M. Ward⁴, Nicholas J. Parr⁵

Affiliations

¹ Clinician Investigator, ESP Coordinating Center, Portland VA Health Care System Portland, OR
² Senior Research Associate, ESP Coordinating Center, Portland VA Health Care System Portland, OR
³ Research Associate, ESP Coordinating Center, Portland VA Health Care System Portland, OR
⁴ Research Assistant, ESP Coordinating Center, Portland VA Health Care System Portland, OR
⁵ Associate Director, ESP Coordinating Center, Portland VA Health Care System Portland, OR

PMID: 36001737
Bookshelf ID: NBK583217

Excerpt

The Evidence Synthesis Program (ESP) Coordinating Center is responding to a request from the VHA National Radiation Oncology Program (NROP) for an Evidence Brief updating a 2015 ESP evidence review on the benefits and harms of proton beam therapy (PBT) for localized prostate cancer. Findings from this report will be used to inform NROP policies on the provision of PBT for the treatment of prostate cancer.

Publication types

Review